Ethics and Compliance Program Sample Clauses

Ethics and Compliance Program. Seller acknowledges and accepts full and sole responsibility to maintain an ethics and compliance program appropriate for its business throughout the performance of this Contract. Buyer strongly encourages Seller to model its program in accordance with the Federal Sentencing Guidelines, applicable guidance from enforcement authorities, and industry best practices. Seller shall publicize to its employees who are engaged in the performance of work under the Contract that they may report any concerns of misconduct by Buyer or any of its employees or agents by going to Ethics@Boeing. Seller shall convey the substance of this clause to its suppliers.
Sample 1Sample 2Sample 3See All (66)
AutoNDA by SimpleDocs
Ethics and Compliance Program. Seller acknowledges and accepts full and sole responsibility to maintain an ethics and compliance program appropriate for its business throughout the performance of this Contract. Buyer strongly encourages Seller to model its program in accordance with the U.S. Sentencing Commission Guidelines, applicable guidance from enforcement authorities, and industry best practices. Seller shall publicize to its employees who are engaged in the performance of work under this Contract that they may report any concerns of misconduct by Buyer or any of its employees or agents by going to xxxxx://xxx.xxxxxx.xxx/principles/xxxxxx-xxx-xxxxxxxxxx.xxxx. Seller shall convey the substance of this provision to its suppliers.
Sample 1Sample 2Sample 3See All (21)
Ethics and Compliance Program. Seller acknowledges and accepts full and sole responsibility to maintain an ethics and compliance program appropriate for its business throughout the performance of this PO. Seller will publicize to its employees who are engaged in the performance of work under this PO that they may report any concerns of misconduct by Jeppesen or any of its employees or agents by going to xxxxxx@xxxxxx.xxx. Seller will convey the substance of this clause to its suppliers.
Sample 1Sample 2Sample 3See All (12)
Ethics and Compliance Program. Seller acknowledges and accepts full and sole responsibility to maintain an ethics and compliance program appropriate for its business throughout the performance of this agreement.
Sample 1Sample 2
Ethics and Compliance Program. During the term of this Agreement, Hydro USA shall maintain a comprehensive ethics and compliance program applicable to all of Hydro USA’s operations, facilities, subsidiaries, and Employees. The ethics and compliance program shall be designed to promote an organizational culture within Hydro USA that encourages ethical conduct and compliance by all Employees; effectively identifies and addresses all applicable ethics and compliance issues, including ensuring accurate collection, tracking, and reporting of data submitted to governmental entities; and effectively prevents and detects violations of applicable laws, statutes, regulations, permits, agreements, orders, and internal manuals, policies, and procedures. Hydro USA shall ensure that the ethics and compliance program includes, but is not limited to, the following elements: Code of Conduct; Whistleblower System including a hotline, options for anonymous reports by Employees and third-parties, Non-Retaliation Policy, and a system for documenting, tracking, and investigating all reports; comprehensive training; auditing; risk management; and policies and procedures reasonably necessary to establish, define, enforce, manage, and promote each element of the ethics and compliance program. Hydro USA shall maintain its ethics and compliance program in a manner designed to ensure the program is fully integrated and standardized throughout Hydro USA’s operations, facilities, and subsidiaries. Pursuant to Norsk Hydro’s Code of Governance, attached herein as Attachment 23, Hydro USA shall implement its ethics and compliance program throughout its organization in a manner that complies and is aligned, where applicable, with Norsk Hydro’s global governance documents and procedures (or substantially similar replacement documents) including, but not limited to: Health, Safety, Security, Environment Global Directive (attached hereto as Attachment 19); HSE Management System Audit Global Procedure (attached hereto as Attachment 20); HSE Risk Management Global Procedure (attached hereto as Attachment 21); HSE Incident Management Global Procedure (attached hereto as Attachment 22); Code of Governance (attached hereto as Attachment 23); Compliance System for Managing Compliance Risks Global Procedure (attached hereto as Attachment 24); Alert Case Management Global Procedure (attached hereto as Attachment 25); Integrity Risk Management of Agents and Intermediaries Global Procedure (attached hereto as Attachment 26); Integri...
Sample 1
Ethics and Compliance Program. MTS has been adopting, implementing, and maintaining a self-governance program that includes a business ethics and compliance program that applies to all employees, both domestic and international. MTS shall continue to implement this program so as to ensure that MTS and each of its employees maintains the business honesty and integrity required of a Government contractor and that MTS operates in strict compliance with all applicable laws, regulations, and the terms of any contract, grant, or cooperative agreement. Specifically:
Sample 1
Ethics and Compliance Program. 9.1 AXA Philippines’ applies the highest standards in terms of ethics and integrity in the conduct of its activities and has notably established a Compliance and Ethics Code and an Anti-corruption Code of Conduct that govern the conditions under which its employees must conduct their activities and their relationships with third parties. In this respect, AXA Philippines expects its Third Partys to share the same highest standards.
Sample 1
AutoNDA by SimpleDocs

Related to Ethics and Compliance Program

  • Compliance Program The Company has established and administers a compliance program applicable to the Company, to assist the Company and the directors, officers and employees of the Company in complying with applicable regulatory guidelines (including, without limitation, those administered by the FDA, the EMA, and any other foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA or EMA); except where such noncompliance would not reasonably be expected to have a Material Adverse Effect.

  • Anti-Money Laundering Compliance Programs Soliciting Dealer represents to the Dealer Manager and to the Company that it has established and implemented anti-money laundering compliance programs in accordance with applicable law, including applicable FINRA Conduct Rules, the Exchange Act Rules and Regulations and the Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act of 2001, as amended (the “USA PATRIOT Act”), specifically including, but not limited to, Section 352 of the International Money Laundering Abatement and Anti-Terrorist Financing Act of 2001 (the “Money Laundering Abatement Act,” and together with the USA PATRIOT Act, the “AML Rules”) reasonably expected to detect and cause the reporting of suspicious transactions in connection with the offering and sale of the Shares. Soliciting Dealer further represents that it currently is in compliance with all AML Rules, specifically including, but not limited to, the Customer Identification Program requirements under Section 326 of the Money Laundering Abatement Act, and Soliciting Dealer hereby covenants to remain in compliance with such requirements and shall, upon request by the Dealer Manager or the Company, provide a certification to the Dealer Manager or the Company that, as of the date of such certification (a) its AML Program is consistent with the AML Rules, and (b) it is currently in compliance with all AML Rules, specifically including, but not limited to, the Customer Identification Program requirements under Section 326 of the Money Laundering Abatement Act. Upon request by the Dealer Manager at any time, Soliciting Dealer will (i) furnish a written copy of its AML Program to the Dealer Manager for review, and (ii) furnish a copy of the findings and any remedial actions taken in connection with its most recent independent testing of its AML Program.

  • Clinical Data and Regulatory Compliance The preclinical tests and clinical trials conducted or sponsored by the Company (collectively, “studies”) that are described in, or the results of which are referred to in, the Registration Statement, the Time of Sale Prospectus or the Prospectus were and, if still pending, are, to the Company’s knowledge, being conducted in all material respects in accordance with the protocols, procedures and controls designed and approved for such studies and with standard medical and scientific research procedures; each description of the results of such studies is reasonably accurate and complete in all material respects in the context of the experimental set-up and fairly presents the data derived from such studies within the limits of interpretation by people trained in the trade, and the Company and its subsidiaries have no knowledge of any other studies the results of which are inconsistent with, or otherwise call into question, the results described or referred to in the Registration Statement, the Time of Sale Prospectus or the Prospectus; the Company and its subsidiaries have made all such filings and obtained all such approvals as may be required by the Food and Drug Administration of the U.S. Department of Health and Human Services or any committee thereof or from any other U.S. or foreign government or drug or medical device regulatory agency, or health care facility Institutional Review Board (collectively, the “Regulatory Agencies”) for the operation of the Company’s business as currently conducted, except as could not be expected, individually or in the aggregate, to have a Material Adverse Effect; neither the Company nor any of its subsidiaries has received any notice of, or correspondence from, any Regulatory Agency requiring the termination, suspension or modification of any clinical trials that are described or referred to in the Registration Statement, the Time of Sale Prospectus or the Prospectus; and the Company and its subsidiaries have each operated and currently are in compliance in all material respects with all applicable rules and regulations of the Regulatory Agencies, except as could not be expected, individually or in the aggregate, to have a Material Adverse Effect.

  • Compliance Program of the Sub-Adviser The Sub-Adviser hereby represents and warrants that:

  • Money Market Fund Compliance Testing and Reporting Services Subject to the authorization and direction of the Trust and, in each case where appropriate, the review and comment by the Trust’s independent accountants and legal counsel, and in accordance with procedures that may be established from time to time between the Trust and the Administrator, the Administrator will:

Time is Money Join Law Insider Premium to draft better contracts faster.